XML 27 R16.htm IDEA: XBRL DOCUMENT v3.21.2
Derivative Instruments
 9 Months Ended
Sep. 30, 2021
Derivative Instruments Disclosure [Abstract]  
Derivative Instruments and Hedging Activities Disclosure [Text Block] Derivative Instruments
The Company uses derivative instruments, specifically forward foreign exchange contracts, to manage the risk associated with the volatility of future cash flows. The foreign exchange contracts are used to mitigate the impact of exchange rate fluctuations on certain forecasted purchases of inventory and are designated as cash flow hedging instruments. As of September 30, 2021, the Company's entire net forward contracts hedging portfolio consisted of a notional amount of $26,648, with the fair value included on the Consolidated Balance Sheets in other current assets of $268 and other current liabilities of $86. For the three and nine months ended September 30, 2021, the Company's hedging activities were considered effective, and, thus, no ineffectiveness from hedging activities was recognized in the Consolidated Statements of Income/(Loss) during the nine months of 2021. The following table presents the pre-tax amounts from derivative instruments affecting income and other comprehensive income/loss ("OCI") for the periods ended September 30, 2021 and 2020, respectively:

Three Months Ended September 30,Nine Months Ended September 30,
Forward Contracts:Location of Gain or Loss Recognized in Net Income on DerivativeGain/(Loss) Recognized in Accumulated OCILoss Reclassified into Income From Accumulated OCIGain Recognized in Accumulated OCILoss Reclassified into Income From Accumulated OCI
2021
Cost of Sales (exclusive of depreciation and amortization)
$274 $(53)$880 $(765)
2020
Cost of Sales (exclusive of depreciation and amortization)
(478)(147)152 (59)